Blood and cellular technologies with global manufacturing and apheresis platforms
Terumo Blood and Cell Technologies operates a manufacturing-heavy organization spanning 5,001–10,000 employees across 16+ countries, focused on blood component separation, therapeutic apheresis, and cellular processing. The company is mid-migration from SAP ECC to S/4HANA while simultaneously adopting Fiori, Master Data Governance, and manufacturing execution systems (MES) and IIoT—a multi-year transformation that mirrors their concurrent shift toward real-time embedded analytics and process harmonization across a fragmented global footprint.
Notable leadership hires: Marketing Director
Terumo Blood and Cell Technologies, headquartered in Lakewood, Colorado, manufactures and distributes blood component separation equipment, apheresis systems, and cellular technologies to healthcare providers in over 150 countries. Founded in 1964 as COBE Laboratories, the company is the only player combining apheresis collection, manual and automated whole blood processing, and pathogen reduction in a single portfolio. The business serves hospitals, blood banks, and therapeutic centers through a direct and indirect sales model, operating manufacturing facilities and R&D centers across North America, Europe, and Asia-Pacific. Active hiring spans engineering, manufacturing operations, and finance, with particular focus on new product introduction and design transfer initiatives.
Primary platform is SAP (ECC, S/4HANA, Fiori, Analytics Cloud, MII), plus manufacturing-focused tools: MES, SCADA, LIMS, PLM, and CMMS. Analytics: Power BI, SQL, Python. Infrastructure: Azure, Windows, Linux.
Active projects: SAP S/4HANA transformation, new product introduction, design transfer to manufacturing, automated manufacturing systems, real-time embedded analytics with Fiori and SAP Analytics Cloud, and global process harmonization.
Other companies in the same industry, closest in size